Skip to main content
Contact Us
Subscribe
E-Edition
46°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Stevanato Group S.p.A. Ordinary Shares
(NY:
STVN
)
20.56
-0.78 (-3.66%)
Official Closing Price
Updated: 7:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Stevanato Group S.p.A. Ordinary Shares
< Previous
1
2
3
Next >
Stevanato Group to Present at Upcoming Investor Conferences
November 11, 2024
From
Stevanato Group
Via
Business Wire
Stevanato Group Reports Financial Results for the Third Quarter of 2024
November 05, 2024
From
Stevanato Group
Via
Business Wire
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
October 22, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
October 01, 2024
From
Stevanato Group
Via
Business Wire
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
September 26, 2024
From
Stevanato Group
Via
Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
August 29, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Reports Financial Results for the Second Quarter of 2024
August 06, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024
July 25, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges
May 30, 2024
From
Stevanato Group
Via
Business Wire
Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro
May 28, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Announces Results of Annual General Meeting
May 24, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
May 23, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Reports Financial Results for the First Quarter of 2024
May 09, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
May 01, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
April 25, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group appoints Ugo Gay as Chief Operations Officer
April 04, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
March 26, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
March 21, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Announces Public Offering of Ordinary Shares
March 20, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
March 11, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
March 07, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
February 22, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization
January 24, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing
November 16, 2023
From
Stevanato Group
Via
Business Wire
Stevanato Group to Present at the Jefferies London Healthcare Conference
November 09, 2023
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Reports Third Quarter 2023 Financial Results
October 31, 2023
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023
October 17, 2023
From
Stevanato Group S.p.A.
Via
Business Wire
Stevanato Group Announces Voting Results from its Extraordinary General Meeting
October 05, 2023
From
Stevanato Group S.p.A.
Via
Business Wire
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028
September 26, 2023
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END
Via
FinancialNewsMedia
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.